These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6385266)

  • 21. Mitoxantrone and cyclophosphamide in patients with advanced breast cancer.
    Ehninger G; Weible KH; Heidemann EG; Waller HD
    Cancer Treat Rep; 1984 Oct; 68(10):1283-4. PubMed ID: 6525600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitoxantrone: a new anticancer drug with significant clinical activity.
    Shenkenberg TD; Von Hoff DD
    Ann Intern Med; 1986 Jul; 105(1):67-81. PubMed ID: 3521429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L; Bramwell V; Moran LA
    Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of mitoxantrone and doxorubicin in breast cancer.
    Neidhart JA; Gochnour D; Roach R; Hoth D; Young D
    J Clin Oncol; 1986 May; 4(5):672-7. PubMed ID: 3517241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined mitoxantrone plus doxorubicin in the treatment of breast cancer.
    Stewart DJ; Perrault DJ; Maroun JA; Lefebvre BM
    Am J Clin Oncol; 1987 Aug; 10(4):335-40. PubMed ID: 3618544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitoxantrone as first-line chemotherapy for advanced breast cancer: results of a European collaborative study.
    Smyth JF; Cornbleet MA; Stuart-Harris RC; Smith IE; Coleman RE; Rubens RD; McDonald M; Mouridsen HT; Rainer H; van Oosterom AT
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):15-8. PubMed ID: 6484578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitoxantrone in refractory nonHodgkin's lymphoma. A Southwest Oncology Group study.
    Coltman CA; Coltman TM; Balcerzak SP; Morrison FS; Von Hoff DD
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):50-3. PubMed ID: 6484581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I trial of high-dose mitoxantrone plus cyclophosphamide and filgrastim in patients with advanced breast carcinoma.
    Sparano JA; Robert N; Silverman P; Lazarus H; Malik U; Venkatraj U; Sarta C
    J Clin Oncol; 1996 Sep; 14(9):2576-83. PubMed ID: 8823338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitoxantrone in malignant lymphoma.
    Gams RA; Bryan S; Dukart G; Weiss A; Case D; Jones S; Stein R
    Invest New Drugs; 1985; 3(2):219-22. PubMed ID: 4019123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of mitoxantrone on a daily X 5 schedule.
    Goldsmith MA; Ohnuma T; Jaffrey IH; Greenspan EM; Holland JF
    Am J Clin Oncol; 1984 Oct; 7(5):567-70. PubMed ID: 6507380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mitoxantrone in a combination regimen in advanced breast cancer].
    Hausmaninger H
    Wien Med Wochenschr; 1985 Dec; 135(23-24):594-7. PubMed ID: 4096006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitoxantrone as a first-line treatment of advanced breast cancer.
    Landys K; Borgstrom S; Andersson T; Noppa H
    Invest New Drugs; 1985; 3(2):133-7. PubMed ID: 4019117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.
    Bennett JM; Muss HB; Doroshow JH; Wolff S; Krementz ET; Cartwright K; Dukart G; Reisman A; Schoch I
    J Clin Oncol; 1988 Oct; 6(10):1611-20. PubMed ID: 3049953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase I trial of ametantrone acetate (NSC-287513).
    Gams RA; Ostroy F; Bender JF; Grillo-López AJ
    Invest New Drugs; 1985; 3(4):383-8. PubMed ID: 4086246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety assessment of a new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. I. Clinical observations.
    Henderson BM; Dougherty WJ; James VC; Tilley LP; Noble JF
    Cancer Treat Rep; 1982 May; 66(5):1139-43. PubMed ID: 7083216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer].
    Ito Y; Hoshino A; Ohara K; Kamiya O; Nagata K; Kojima T; Kinoshita T; Sugiura I
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1999-2003. PubMed ID: 4051516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitoxantrone in relapsed and refractory acute leukemia.
    Prentice HG; Robbins G; Ma DD; Ho AD
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):32-5. PubMed ID: 6385263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I-II trial of mitoxantrone in acute leukemia.
    Arlin ZA; Silver R; Cassileth P; Armentrout S; Gams R; Daghestani A; Coleman M; Schoch I; Dukart G
    Cancer Treat Rep; 1985 Jan; 69(1):61-4. PubMed ID: 3855386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.
    Greco FA; Hainsworth JD
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-61-S17-64. PubMed ID: 9374096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I study of a 5-day schedule of mitoxantrone (dihydroxyanthracenedione).
    Wynert WR; Harvey HA; Lipton A; Schweitzer J; White DS
    Cancer Treat Rep; 1982 Jun; 66(6):1303-6. PubMed ID: 7083234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.